Hearing disorders, genetic predisposition, and risk of new-onset atrial fibrillation: A prospective cohort study in the UK biobank

被引:1
|
作者
Hou, Yabing [1 ]
Yang, Hongxi [2 ]
Xu, Yanning [3 ,4 ]
Wang, Kan [4 ]
Fu, Yinghong [1 ]
Lu, Zuolin [5 ]
机构
[1] Capital Med Univ, Yanjing Med Coll, Dept Med Informat Technol & Management, Beijing, Peoples R China
[2] Tianjin Med Univ, Sch Basic Med Sci, Dept Bioinformat, Tianjin, Peoples R China
[3] Univ Med Ctr Rotterdam, Dept Internal Med, Erasmus MC, Rotterdam, Netherlands
[4] Univ Med Ctr Rotterdam, Dept Epidemiol, Erasmus MC, Rotterdam, Netherlands
[5] Chinese Acad Med Sci & Peking Union Med Coll, Sch Populat Med & Publ Hlth, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
Atrial fibrillation; Hearing difficulty; Tinnitus; Genetic risk score; population -based study; STRESS;
D O I
10.1016/j.ijcard.2024.131829
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Atrial fibrillation (AF) is the most common sustained arrhythmia and is associated with significant morbidity and mortality. Hearing impairment has been linked to several cardiovascular diseases. However, the association between hearing disorders, genetic predisposition, and new -onset AF remains largely unknown. Methods: A total of 476,773 participants (mean age 56.5 years) free of AF at baseline (from 2006 to 2010) were included from the UK Biobank study. The presence of hearing disorders including hearing difficulty and tinnitus was self -reported through the touchscreen questionnaire. AF was defined using ICD-10 code: I48 and was followed till February 1st. 2022. The Cox model was used to calculate hazard ratios (HRs) and 95% confidence intervals (95% CI). Results: During a median follow-up of 13.0 years, the AF incidence rate was 2.9 per 1000 person -years. After adjustments for potential confounders, the presence of hearing difficulty (HR, 1.35; 95% CI: 1.32-1.39) and the use of hearing aid (1.45; 1.37-1.53) were significantly associated with risk of new -onset AF. Compared to individuals without tinnitus, the AF risk increased by 17% among those who experienced tinnitus occasionally (1.17; 1.09-1.25), 23% among those who experienced tinnitus frequently (1.23; 1.10-1.39), and 32% among those who experienced tinnitus consistently (1.32; 1.22-1.42). No significant difference was observed across different groups of genetic risk score for AF onset. Conclusions: Our study provides evidence regarding significant associations of hearing difficulty, use of hearing aid, and tinnitus with risk of incident AF. Findings highlight the potential that screening hearing disorders can benefit AF prevention.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Imaging-based body fat depots and new-onset atrial fibrillation in general population: a prospective cohort study
    Lu, Zuolin
    Tilly, Martijn J.
    Aribas, Elif
    Bos, Daniel
    Geurts, Sven
    Stricker, Bruno H.
    de Knegt, Robert
    Ikram, M. Arfan
    de Groot, Natasja M. S.
    Voortman, Trudy
    Kavousi, Maryam
    BMC MEDICINE, 2022, 20 (01)
  • [22] New-onset atrial fibrillation and thromboembolic risk: Cardiovascular syzygy?
    Procter, Nathan E. K.
    Stewart, Simon
    Horowitz, John D.
    HEART RHYTHM, 2016, 13 (06) : 1355 - 1361
  • [23] Impaired Left Atrial Strain is a Risk Factor for New-Onset Atrial Fibrillation
    Sherer, Jason
    Dahan, Shani
    Plakht, Ygal
    Al-Alusi, Mostafa
    Khurshid, Shaan
    Lubitz, Steven A.
    Ellinor, Patrick T.
    Van Kampen, Antonia
    Hung, Judy
    CIRCULATION, 2023, 148
  • [24] Risk Factors for the Development of New-Onset Persistent Atrial Fibrillation: Subanalysis of the VITAL Study
    Middeldorp, Melissa E.
    Sandhu, Roopinder K.
    Mao, Jessica
    Gencer, Baris
    Danik, Jacqueline S.
    Moorthy, Vinayaga
    Cook, Nancy R.
    Albert, Christine M.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2023, 16 (12) : 651 - 662
  • [25] Risk factors for new-onset atrial fibrillation during critical illness: A Delphi study
    Bedford, Jonathan P.
    Garside, Tessa
    Darbyshire, Julie L.
    Betts, Timothy R.
    Young, J. Duncan
    Watkinson, Peter J.
    JOURNAL OF THE INTENSIVE CARE SOCIETY, 2022, 23 (04) : 414 - 424
  • [26] Transesophageal echocardiography for cardiovascular risk estimation in patients with sepsis and new-onset atrial fibrillation: a multicenter prospective pilot study
    Vincent Labbé
    Stephane Ederhy
    Nathanael Lapidus
    Jérémie Joffre
    Keyvan Razazi
    Laurent Laine
    Oumar Sy
    Sebastian Voicu
    Frank Chemouni
    Nadia Aissaoui
    Roland Smonig
    Denis Doyen
    Fabrice Carrat
    Guillaume Voiriot
    Armand Mekontso-Dessap
    Ariel Cohen
    Muriel Fartoukh
    Annals of Intensive Care, 11
  • [27] Transesophageal echocardiography for cardiovascular risk estimation in patients with sepsis and new-onset atrial fibrillation: a multicenter prospective pilot study
    Labbe, Vincent
    Ederhy, Stephane
    Lapidus, Nathanael
    Joffre, Jeremie
    Razazi, Keyvan
    Laine, Laurent
    Sy, Oumar
    Voicu, Sebastian
    Chemouni, Frank
    Aissaoui, Nadia
    Smonig, Roland
    Doyen, Denis
    Carrat, Fabrice
    Voiriot, Guillaume
    Mekontso-Dessap, Armand
    Cohen, Ariel
    Fartoukh, Muriel
    ANNALS OF INTENSIVE CARE, 2021, 11 (01)
  • [28] Electrocardiographic parameters and the risk of new-onset atrial fibrillation in the general population: the Rotterdam Study
    Geurts, Sven
    Tilly, Martijn J.
    Kors, Jan A.
    Deckers, Jaap W.
    Stricker, Bruno H. C.
    de Groot, Natasja M. S.
    Ikram, M. Arfan
    Kavousi, Maryam
    EUROPACE, 2023, 25 (06):
  • [29] Ultraprocessed food consumption, genetic predisposition, and the risk of gout: the UK Biobank study
    Zhang, Tingjing
    Xu, Xin
    Chang, Qing
    Lv, Yanling
    Zhao, Yuhong
    Niu, Kaijun
    Chen, Liangkai
    Xia, Yang
    RHEUMATOLOGY, 2024, 63 (01) : 165 - 173
  • [30] Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19
    Kensara, Raed
    Aljuhani, Ohoud
    Korayem, Ghazwa B.
    Alkofide, Hadeel
    Almohareb, Sumaya N.
    Alosaimi, Yousef S.
    Altebainawi, Ali F.
    Bin Saleh, Khalid
    Andas, Norah Al
    Harbi, Shmeylan Al
    Harthi, Abdullah F. Al
    Ashkan, Uhood
    Alghamdi, Rema
    Badreldin, Hisham A.
    Hafiz, Awatif
    AlFaifi, Mashael
    Alqahtani, Rahaf A.
    Vishwakarma, Ramesh
    Alenazi, Abeer A.
    Alalawi, Mai
    Mahboob, Reem
    Alfouzan, Renad A.
    Al Tuhayni, Layan B.
    Qahtani, Nouf Al
    Sulaiman, Khalid Al
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29